Charley Grant

Industrials and health care for @wsjheard. Heralded by critics as "most lamentable.”

Categories
N/A
Content Types
N/A
More Information
Location|Languages
Publications
N/A

Published Content

355
wsj.com
Article
How Many More Tears at Johnson & Johnson?
December, 15 2018
jp.wsj.com
Article
米大リーグ、公式バットが中国ブランドになる日
December, 9 2018
jp.wsj.com
Article
武田薬品株は安すぎる、シャイアー買収決戦前夜
December, 4 2018
wsj.com
Article
Biotech Looks Ready for Its Deal Test
November, 30 2018
wsj.com
Article
Pharma Stocks Soothe Stock-Market Malady
November, 23 2018
wsj.com
Article
Biotech Learns the Magic Word
November, 19 2018
jp.wsj.com
Article
テスラの記録的決算、どう作られたか
November, 6 2018
wsj.com
Article
How Tesla Made a Record Profit
November, 5 2018
wsj.com
Article
Teva Passes Its Check-Up
November, 1 2018
wsj.com
Article
Investors Frown on Biotech Famed for Emojis
October, 26 2018
jp.wsj.com
Article
テスラ好決算、すべての問題払拭とはならず
October, 25 2018
wsj.com
Article
Encouraging Test Results for Health-Care Giants
October, 16 2018
wsj.com
Article
Tax Credit for $35,000 Tesla Model 3 Slips Away
October, 12 2018
wsj.com
Article
Biotech Is Down but Far From Out
October, 10 2018
wsj.com
Article
The Future at Perrigo Is Brighter Than Investors Think
October, 9 2018
wsj.com
Article
Surf’s Up, Wheels Up at United Airlines
October, 5 2018
jp.wsj.com
Article
バイオ医薬品会社の買収、干上がっている訳は
October, 5 2018
wsj.com
Article
Why Biotech Deal-Making Has Dried Up
October, 4 2018
wsj.com
Article
Something Happened at Pfizer?
October, 1 2018
jp.wsj.com
Article
テスラ出直し、新会長を待ち受ける仕事とは
October, 1 2018
wsj.com
Article
Tesla Gets a Second Chance
September, 30 2018
jp.wsj.com
Article
テスラ正念場、投資家が目覚めるのはまだ先か
September, 28 2018
wsj.com
Article
Truth and Consequences for Elon Musk and Tesla
September, 27 2018
wsj.com
Article
Easy Come, Easy Go in Biotech
September, 27 2018
wsj.com
Article
Some Good News From Rite Aid? It Is Possible
September, 26 2018
wsj.com
Article
Surprise Heart Data Is Just the Beginning for Amarin
September, 24 2018
wsj.com
Article
Teva Investors Get Headache Relief
September, 17 2018
wsj.com
Article
The Worst Is Over for Generic-Drug Stocks
September, 14 2018
jp.wsj.com
Article
テスラの財務責任者、相次ぐ「脱走」の真相は
September, 8 2018
wsj.com
Article
What Scared Off Tesla’s Accountant?
September, 7 2018
jp.wsj.com
Article
テスラの運命変えたマスク氏の2つの決断
August, 25 2018
wsj.com
Article
How Two Musk Decisions in 2016 Put Tesla Into Trouble
August, 24 2018
wsj.com
Article
Abbott Labs Is a Rare Growth Story in Health Care
August, 20 2018
jp.wsj.com
Article
テスラ、SECの調査で形勢一変 資金調達に壁
August, 17 2018
wsj.com
Article
The Game Has Changed at Tesla
August, 17 2018
wsj.com
Article
Why Mylan, Not Tesla, Is the Buyout to Bet On
August, 8 2018
jp.wsj.com
Article
テスラ非公開化の夢、残る数々の疑問
August, 7 2018
wsj.com
Article
Tesla’s Go-Private Dream Doesn’t Add Up
August, 7 2018
jp.wsj.com
Article
テスラの見通し、投資家好感も要注意
August, 2 2018
wsj.com
Article
Tesla Profits: Be Careful What You Wish For
August, 1 2018
wsj.com
Article
MiMedx Gets Delisting Notice From Nasdaq
July, 26 2018
wsj.com
Article
Caution Still Needed on Biogen Alzheimer’s Bounty
July, 26 2018
jp.wsj.com
Article
テスラは「寄付」が命綱に、資金繰り探るマスク氏
July, 23 2018
wsj.com
Article
Tesla Wants Its Money Back
July, 23 2018
wsj.com
Article
Biotech IPO Boom Comes With Side Effects
July, 18 2018
jp.wsj.com
Article
株価を押し上げる「取り残される不安」
July, 13 2018
wsj.com
Article
Fear of Missing Out Drives Stock Performance
July, 13 2018
wsj.com
Article
Drug Supply Chain Feels the Trump Effect
July, 11 2018
wsj.com
Article
Don’t Chase Biogen Into the Unknown on Alzheimer’s
July, 6 2018
wsj.com
Article
Why July Is a Risky Month for Drug Price Backlash
July, 3 2018
Authorship Stats
2Sites355Projects32,792Words
About
Charley Grant is a writer who has produced content for wsj.com and jp.wsj.com
Key Phrases
Wall Street, Mr Musk, Drug Prices, Drug Companies, Elon Musk, Health Care, Price Increases, Chief Executive, Rite Aid, Cash Flow
© ClearVoice, Inc.